Protalix
What if diseases that currently have no effective treatment could be relieved using proteins that plant cells make? Protalix, a NASDAQ-traded biopharmaceutical company, is developing and commercializing drugs manufactured with their proprietary platform. They needed a fresh look and feel — an overhaul to their website and communication materials. So we helped them achieve precisely that. We brought a modern look to two websites (corporate and a site for phase III studies), prepared their clinical presentations, and helped with the collateral for the exhibitions. Always with extremely tight schedules, but always a joy to do.
Ronen Rosenberg
VP Commercial and Product Planning
We have been working with Candensee for quite a few years creating many of Protalix’s communication materials. Their professionalism and medical marcom expertise is evident from the first interaction and throughout our work. They have been able to work in tight timelines, be creative and not lose sight of detail.
